How the Mounjaro dose schedule works — and why it's built the way it is

Why does the schedule start so low, is 2.5 mg doing anything?

This is probably the question our prescribers hear most often in the first few weeks of treatment. The 2.5 mg pen exists primarily so your digestive system can get used to the way tirzepatide slows gastric emptying. Nausea, mild indigestion and loose stools are common early on; starting gently reduces how disruptive those effects are. Think of it less as a treatment dose and more as an introduction, your gut meeting a new signal for the first time.

The dose does have some biological activity, and some people notice appetite changes even at 2.5 mg. But the significant weight-management effect builds as the dose rises. SURMOUNT-1, the pivotal trial published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks, figures that accumulated across the full titration period, not just the maintenance phase.

Staying at 2.5 mg for four full weeks before moving up isn't optional, it's how the schedule is designed. Rushing the titration generally means more side effects, not faster results. Your prescriber reviews your progress before any dose change, and that review is exactly what the clinical reassessment before each repeat order at each stage of the titration is designed to catch.

What does the full dosage schedule for tirzepatide look like from start to maintenance?

The licensed schedule runs through six strengths in sequence. Most people follow this path:

Weeks 1–4: 2.5 mg. Weeks 5–8: 5 mg, the first step up from the introductory dose, brings you into a range where the appetite-suppressing effects of tirzepatide typically become more noticeable. Weeks 9–12: 7.5 mg. Weeks 13–16: 10 mg. Weeks 17–20: 12.5 mg. Week 21 onwards: 15 mg.

That puts the majority of patients at maintenance somewhere between five and six months in, assuming no pauses and no tolerability concerns at any step. In practice, some people stay longer at a particular dose because side effects need more time to settle, or because their prescriber wants to see how they respond before continuing. That is not a failure; it is the schedule working as intended.

It's also worth knowing that 15 mg is the ceiling, not a compulsory destination. If someone responds well and tolerates 10 mg comfortably, a prescriber may decide to maintain at that level. The right maintenance dose is the one that suits you clinically, not the highest one available.

For context on what private treatment costs across the dose range, the Mounjaro price comparison page sets out the market picture honestly.

Can the schedule be paused, slowed or reversed?

Yes, and for good reasons. If a dose increase brings on nausea or gastrointestinal symptoms that don't settle within a couple of weeks, many prescribers will recommend staying at the current dose for another four weeks before trying again. That flexibility is built into clinical guidance, not a deviation from it.

Stepping back down is also possible. If a higher dose proves genuinely difficult to tolerate even after giving it adequate time, returning to the previous strength is a legitimate clinical option. The aim is to find the dose you can sustain, not the dose that looks best on paper.

What you should not do is adjust your own dose, split a pen, or take a partial dose of Mounjaro without clinical guidance. The KwikPen delivers a fixed amount; the pen mechanism isn't designed for partial use, and self-adjusting outside a prescriber's plan carries real risk. If your schedule needs changing, that conversation belongs with your prescriber, not with a forum.

Storage matters throughout: Mounjaro pens should be kept refrigerated at 2–8°C. The Mounjaro Summary of Product Characteristics on the Electronic Medicines Compendium gives the exact room-temperature window, always check the leaflet that comes with your pen rather than relying on third-party timings.

Does following the schedule mean the same injection day each week?

Broadly, yes. Once-weekly means the same day every week, a Monday injection stays a Monday injection. Consistency helps both the pharmacokinetics and your own routine. That said, if you need to shift your injection day by a day or two, there is usually a minimum gap to observe; the Patient Information Leaflet inside your pack covers this clearly, and it's always better to check with your prescriber than to guess.

When your pen arrives (tracked by DPD, in a plain unbranded box) the leaflet is inside. Read it before your first injection, not after. It covers the injection sites (abdomen, thigh or upper arm, rotated each week), the cold-chain requirements, and what to do if a dose is missed. Missed-dose decisions belong to the prescriber and that leaflet; there is no universal answer that applies to everyone.

If you want to understand more about Mounjaro as a whole, including how it works as a dual GIP and GLP-1 receptor agonist, or you'd like to speak to our prescribers about whether this treatment suits your situation, the consultation is free and reviewed the same day by a GPhC-registered Independent Prescriber.